Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Change in Account Payables (2016 - 2026)

Neuroone Medical Technologies filings provide 8 years of Change in Account Payables readings, the most recent being $380240.0 for Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 296.81% to $380240.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $99346.0, a 39.97% increase, with the full-year FY2025 number at $239983.0, up 258.22% from a year prior.
  • Change in Account Payables hit $380240.0 in Q1 2026 for Neuroone Medical Technologies, up from -$439992.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $602635.0 in Q3 2022 to a low of -$439992.0 in Q4 2025.
  • Median Change in Account Payables over the past 5 years was -$14939.0 (2024), compared with a mean of $13194.2.
  • The widest YoY moves for Change in Account Payables: up 3746.27% in 2025, down 2845.26% in 2025.
  • Neuroone Medical Technologies' Change in Account Payables stood at -$154098.0 in 2022, then skyrocketed by 151.61% to $79527.0 in 2023, then tumbled by 118.78% to -$14939.0 in 2024, then tumbled by 2845.26% to -$439992.0 in 2025, then soared by 186.42% to $380240.0 in 2026.
  • The last three reported values for Change in Account Payables were $380240.0 (Q1 2026), -$439992.0 (Q4 2025), and $526943.0 (Q3 2025) per Business Quant data.